Parkintreat 1

Parkintreat 1


باركينتريت 1
Brain Disorders, anti - parkinsonian& al-Zheimer's Drugs
category: use to Zheimer ،
concentration: 1mg

what medicine Parkintreat 1؟

Mechanism: Rasagiline is an irreversible selective inhibitor of monoamine oxidase type B, an enzyme involved in the metabolic degradation of dopamine in the brain. It enhances the effects of levodopa
Uses: in the ttt of Parkinson's disease , either alone or as an adjunct to levodopa therapy to reduce 'end-of-dose' fluctuations in response.
Dosage:The usual dose is the e uivalent ofrasagiline 1 mg once dail .

what scientific name Parkintreat 1؟

what form Parkintreat 1؟

Tablets

what doses Parkintreat 1؟

مرة واحدة يوميا

what company Parkintreat 1؟

sedico/ Inspire

what price Parkintreat 1؟

54 EGP

what company Parkintreat 1؟

sedico/ Inspire

what company Parkintreat 1؟

sedico/ Inspire

Mechanism: Rasagiline is an irreversible selective inhibitor of monoamine oxidase type B, an enzyme involved in the metabolic degradation of dopamine in the brain. It enhances the effects of levodopa
Uses: in the ttt of Parkinson's disease , either alone or as an adjunct to levodopa therapy to reduce 'end-of-dose' fluctuations in response.
Dosage:The usual dose is the e uivalent ofrasagiline 1 mg once dail .


Note: All the provided information about this drug does not substitute for consulting a doctor.

Related tags

Related medicines